We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for crisantaspase (PPD Australia Pty Ltd)
Active ingredients
crisantaspase
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
lyophilized powder for solution for injection/infusion
Indication
Indicated in combination with other chemotherapeutic agents to treat patients with paediatric acute lymphoblastic leukaemia (ALL)
Therapeutic area
Oncology